Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid–Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial)

BACKGROUND: Patients with peripheral artery disease (PAD) experience significant morbidity and mortality. The OMEGA-PAD I Trial, a randomized, double-blinded, placebo-controlled trial, addressed the hypothesis that short-duration, high-dose n-3 polyunsaturated fatty acids (n-3 PUFA) oral supplementa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Grenon, S Marlene, Owens, Christopher D, Nosova, Emily V, Hughes-Fulford, Millie, Alley, Hugh F, Chong, Karen, Perez, Sandra, Yen, Priscilla K, Boscardin, John, Hellmann, Jason, Spite, Matthew, Conte, Michael S
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599461/
https://ncbi.nlm.nih.gov/pubmed/26296857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.115.002034
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars